What's Going On With Novavax Stock Today?

NovavaxInc NVAX shares have been halted since the pre-market session as the U.S. Food and Drug Administrationholds ameeting to determine the fate ofthe company's COVID-19 vaccine.

A committee of independent FDA vaccinationadvisorshave beenassessing the safety of the company's vaccine on Tuesdayat aFDA Advisory Committee meeting.

The committee aims to decide whether or notit should recommendthe Novavax vaccine for adults in the U.S. Following the meeting, the FDA will make a final authorization decision. The Novavax vaccine has already been authorized in several countriesoutside the U.S. It would be the fourth COVID-19 vaccine to receive authorization in the U.S.

Novavax is abiotechnology company thatworks in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases.

NVAX Price Action: Novavax shares have traded between $41.10 and $277.79 over a 52-week period.

The stock remained halted at press time, according to data fromBenzinga Pro.